TumorComparer uses tumor and cell line data to guide experimental model choice; 24 cancers are assessed using NCI TCGA and Sanger COSMIC data. Please cite: Sinha R, et al., 2021.
Tumors: Small blue points; Cell Lines: Labeled points; See documentation for more details
Built by Rileen Sinha, Augustin Luna, Nikolaus Schultz, and Chris Sander.
Cancer is a genetic disease, typically marked by widespread somatic alterations (e.g., mutations, copy-number alterations, and gene expression changes). However, not all changes are functionally important—few genes can promote oncogenesis (also termed “cancer drivers”), whereas other altered genes have little effect on the phenotype (termed “passengers”). Furthermore, many research questions focus on particular genes and their activity (e.g., specific signaling pathways, drug targets, etc.). This motivates the need for a flexible method of comparing tumors with potential cell line models by using researcher-selected properties. We present TumorComparer, a computational comparison method based on weighted features to allow expert- and knowledge-driven comparison of tumors and experimental models, such as cell lines or organoids. We apply TumorComparer to the comparison of ∼8,000 tumors and ∼600 cell lines across 24 cancer types as an initial application to provide a general, pan-cancer resource based on knowledge of oncogenic alterations gained from The Cancer Genome Atlas program (TCGA). TumorComparer is a generally applicable method suitable for pre-clinical cancer research and personalized medicine applications where sets of samples need to be assessed for similarity.
https://www.cell.com/cell-reports-methods/fulltext/S2667-2375(21)00084-9
The “Pre-Computed” tab allows users to explore the results of our systematic analysis available in the publication, while the “User Analysis” section provides users the option of running TumorComparer with their own data.
All cancer types from the publication are available. Balloon plots show the most relevant cell lines and a corresponding searchable table.
This tab allows users to run TumorComparer on their own data. Users will upload a zip file containing the input files with a pre-specified naming convention.
NOTE: For large computational pipelines or large amounts of data, it is suggested that users run TumorComparer locally.
Users are should review the publication for more information about these parameters. The default weights were used as part of the systematic analysis.
Users should rely on their understanding of the problem they are trying to address to select weights. Users can use 1 and 0 as a starting point for known cancer gene and default weights if the relative difference in the magnitude in importance between the sets of genes is unknown.
NOTE: You do NOT have to provide input files for all data types (expression: exp, mutation: mut, copy number: cna). Make sure either ALL files for a data type are included OR NONE of them are included, based on your available data.
Below is example data for the various supported data types.
RCM.1 | SW837 | SW1463 | SNU.61 | CaR.1 | |
---|---|---|---|---|---|
AREG | 11.837 | 9.195 | 9.018 | 9.939 | 10.44 |
MLXIPL | 9.513 | 8.823 | 11.749 | 9.008 | 8.029 |
MUC16 | 3.062 | 7.281 | 6.235 | 2.774 | 9.931 |
ADAMTS15 | 6.177 | 5.697 | 5.272 | 6.198 | 6.004 |
HBB | 7.088 | 2.609 | 1.093 | 1.379 | 6.138 |
COL1A1 | 6.967 | 6.647 | 5.955 | 5.993 | 6.891 |
RCM.1 | SW837 | SW1463 | SNU.61 | CaR.1 | |
---|---|---|---|---|---|
ANKRD30A | 0 | 0 | 0 | 0 | 0 |
APC | 1 | 1 | 1 | 1 | 0 |
APOB | 0 | 0 | 0 | 0 | 0 |
ARHGAP35 | 0 | 0 | 0 | 0 | 0 |
ARID1A | 0 | 0 | 0 | 0 | 0 |
ARID1B | 0 | 0 | 0 | 0 | 0 |
Below is an example of GISTIC discretized
RCM.1 | SW837 | SW1463 | SNU.61 | CaR.1 | |
---|---|---|---|---|---|
PFN1P2 | 0 | 0 | 0 | 0 | 0.667 |
PDE4DIP | 0 | 0 | 0 | 0 | 0.667 |
SEC22B | 0 | 0 | 0 | 0 | 0.667 |
NOTCH2NL | 0 | 0 | 0 | 0 | 0.667 |
NBPF10 | 0 | 0 | 0 | 0 | 0.667 |
HFE2 | 0 | 0 | 0 | 0 | 0.667 |
The TumorComparer software package contains a number of additional parameters that might be of interest to users.
We appreciate any feedback/suggestions you may have; please send feedback to publication corresponding authors.
TumorComparer: 0.99.25